HCCB4MAG-58K
MILLIPLEX® Human Circulating Cancer Biomarker Magnetic Bead Panel 4 - Cancer Multiplex Assay
About This Item
Productos recomendados
reactividad de especies
human
Nivel de calidad
fabricante / nombre comercial
Milliplex®
assay range
accuracy: 80-110%
standard curve range: 0.1-100 ng/mL
(L1CAM)
standard curve range: 0.1-100 ng/mL
(Mesothelin)
standard curve range: 0.3-250 ng/mL
(Hepsin)
standard curve range: 1.4-1,000 ng/mL
(CD44)
standard curve range: 1.4-1,000 ng/mL
(Transglutaminase 2 (TGM2))
standard curve range: 13.7-10,000 pg/mL
(EpCAM)
standard curve range: 13.7-10,000 pg/mL
(Midkine)
standard curve range: 2.7-2,000 ng/mL
(ALDH1A1)
standard curve range: 20.6-15,000 pg/mL
(Carbonic Anhydrase IX (CA9))
standard curve range: 27.4-20,000 pg/mL
(Kallekrein-6)
inter-assay cv: <10%
intra-assay cv: <20%
técnicas
multiplexing: suitable
método de detección
fluorometric (Luminex xMAP)
Condiciones de envío
wet ice
Descripción general
MILLIPLEX® Human Circulating Cancer Biomarker Panel 4 is a 10-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum and plasma samples: Aldheyde dehydrogenase 1 Family, Member A1 (ALDH1A1), Carbonic Anhydrase IX (CA9), CD44, Epithelial cell adhesion molecule (EpCAM), Hepsin, Kallikrein-6, Mesothelin, Midkine, Neural cell adhesion Molecule L1 (L1CAM), and Transglutaminase 2 (TGM2). This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.
The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.
Panel Type: Circulating Cancer
Aplicación
- Analytes: Aldheyde dehydrogenase 1 Family, Member A1 (ALDH1A1), Carbonic Anhydrase IX (CA9), CD44, Epithelial cell adhesion molecule (EpCAM), Hepsin, Kallikrein-6, Mesothelin, Midkine, Neural cell adhesion Molecule L1 (L1CAM), Transglutaminase 2 (TGM2)
- Recommended Sample Type: Human serum, plasma or tissue/cell/tumor culture supernatant
- Recommended Sample Dilution: 25 μL per well of 1:5 diluted serum or plasma can be used. Tissue culture supernatant may require a dilution with an appropriate control medium prior to assay
- Assay Run Time: Overnight (16-18 hours) at 2-8°C
- NOTE: min DC for CA9, Midkine, Kallikrein 6 and EpCAM are in pg/mL while the rest of the analyte min DC are in ng/mL
- Research Category: Cancer
- Research Subcategory: Immune Response, Alzheimer′s Disease, Inflammation, Oncology, Tumor Markers
Características y beneficios
Otras notas
Información legal
Palabra de señalización
Danger
Frases de peligro
Consejos de prudencia
Clasificaciones de peligro
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
Órganos de actuación
Respiratory Tract
Código de clase de almacenamiento
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Detection of cancer biomarkers through multiplex cancer assays can accelerate studies of normal homeostasis and tumorigenic processes. See how MILLIPLEX® multiplex cancer assays are advancing various cancer research areas including lung cancer, breast cancer, and immuno-oncology research.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico